# OnCo record nct05737706 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/nct05737706/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "nct05737706", "NCT05737706" ;
  schema:name "Study of MRTX1133 in Patients With Advanced Solid Tumors Harboring a KRAS G12D Mutation"@en ;
  schema:description "A phase 1 trial of MRTX1133 in Non-small-cell lung cancer and Rectal cancer, run by Mirati Therapeutics Inc., recorded as terminated on the registry."@en ;
  schema:url <https://onco.cc/trials/nct05737706/> ;
  schema:dateModified "2026-09-22"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT05737706> ;
  onco:tag "pipeline", "ctgov-ingest" ;
  onco:phase "1" ;
  onco:cancers <https://onco.cc/cancers/nsclc/>, <https://onco.cc/cancers/rectal-cancer/> ;
  onco:drugs <https://onco.cc/drugs/mrtx1133/> ;
  onco:companies <https://onco.cc/companies/bms/> .